HHealth Read More What people ate at the start of a 20-year study was linked to their heart failure oddsOctober 12, 2026 Diet records from the early 2000s offer a window into how everyday food choices and existing health conditions…
HHealth Read More Stopping GLP-1 drugs often brings weight back. A small trial suggests ways to slow itOctober 12, 2026 Maintaining weight loss after medication ends is a difficult transition, prompting researchers to test two practical support options…
HHealth Read More Late-night snacking may affect liver healthOctober 10, 2026 New research led by Oregon Health & Science University suggests you should think twice about indulging in a…
NNutrition Read More Diet drinks with sugar substitutes as effective as water for weight lossOctober 8, 2026 NEWYou can now listen to Fox News articles! Diet drinks containing sugar substitutes were found to be as…
MMedication Read More Promising new weight-loss drugs | The StarOctober 6, 2026 An emerging weight-loss drug could help some obese people with type 2 diabetes shed up to a quarter…
MMedication Read More GLP-1 Users Report More Nail DetachmentsOctober 5, 2026 GLP-1 drugs may be doing more than shrinking waistlines. An early international survey presented at a major…
HHealthcare Read More Doctors And GLP-1 Users Respond To Trump’s ‘Fat Drugs’ CommentsOctober 4, 2026 The use of GLP-1s is skyrocketing throughout the world; 11% of American adults report taking the medications, up…
MMedication Read More Ozempic Rival Retatrutide Delivers 25% Weight Loss In Phase 3 TrialOctober 4, 2026 An experimental weight-loss injection has helped people with obesity lose an average of up to 25 per cent…
MMedication Read More #EASD26: Lilly’s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes – Endpoints NewsOctober 4, 2026 #EASD26: Lilly’s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes Endpoints NewsEli Lilly obesity drug…
MMedication Read More #EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy – Endpoints NewsOctober 1, 2026 #EASD26: Regeneron’s antibody helps patients regain muscle after stopping GLP-1 therapy Endpoints NewsThe Next Frontier for Obesity Drugs Isn’t…
HHealth Read More Semaglutide cuts major heart events, but researchers still cannot fully explain whySeptember 28, 2026 A detailed analysis of the SELECT trial examined how much of the reduction in major heart events could…
MMedication Read More Off-Label Use of Ozempic-Style Drugs Is SurgingSeptember 27, 2026 A large new study suggests weight-loss drugs have quietly moved from medical tool to what one researcher…